Product image of Yescarta (Axicabtagene Ciloleucel) supplied by GNH India

Yescarta

Active Ingredient:
Axicabtagene Ciloleucel
Origin:
EU

Yescarta (Axicabtagene Ciloleucel)

Yescarta (axicabtagene ciloleucel) is a prescription CAR T-cell therapy used to treat certain blood cancers. Administered as a single infusion, it targets CD19-positive cells. Always consult a healthcare provider for suitability and monitoring.

Manufacturer / TM Owner

Kite Pharma Eu B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yescarta is used for the treatment of relapsed or refractory large B-cell lymphoma and certain other blood cancers after two or more prior therapies. It is designed for adult patients whose cancer has not responded to standard treatments or has returned after treatment. This therapy is part of advanced cancer care.

Side Effects

  • After infusion, Yescarta works by reprogramming the patient's own immune cells to recognize and attack cancer cells. Common effects include flu-like symptoms, fever, and chills as the immune system responds. Some patients may experience fatigue or low blood cell counts during recovery.

Precautions & Warnings

  • Yescarta requires administration in a certified medical facility due to the risk of serious side effects. Patients should be monitored closely for signs of infection, cytokine release syndrome, or neurological events. Ensure all healthcare providers are aware of recent treatments and medical history before starting therapy.

Avoid Interactions

  • No direct drug interactions are listed for Yescarta, as it is a personalized cell therapy. However, patients may receive other medications like chemotherapy or supportive drugs before or after infusion. Always inform your healthcare team about all medications, including over-the-counter and herbal products.

Frequently Asked Questions

Yescarta is used to treat certain types of relapsed or refractory blood cancers, such as large B-cell lymphoma, after other treatments have not worked.

Yescarta is given as a single intravenous infusion in a specialized medical center under close supervision.

Common effects include fever, chills, fatigue, and low blood cell counts as the body responds to treatment.

No, Yescarta is a type of CAR T-cell therapy, which uses the patient's own immune cells to fight cancer.

Yescarta must be administered in a certified medical facility equipped to handle CAR T-cell therapies and monitor for side effects.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Axicabtagene Ciloleucel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT